Generic isotretinoin is available in the United States. It is prescribed to treat severe acne that has not responded to other treatments [1].
When does isotretinoin lose patent protection?
The original patent for isotretinoin expired decades ago, allowing for the widespread availability of generic versions. For instance, Accutane, the brand-name formulation, first received FDA approval in 1982 [2].
What are the different brand names for isotretinoin?
While Accutane was the original brand name, generic isotretinoin is now widely available. Other brand names that have been used include Amnesteem, Claravis, Epuris, and Sotret [3].
How is isotretinoin prescribed and monitored?
Isotretinoin is a powerful medication associated with significant risks, including birth defects. Due to these risks, its use is strictly regulated under the iPLEDGE program [4]. Prescribers, pharmacies, and patients must register and comply with specific requirements to ensure safe distribution and use. Patients must agree to use two forms of contraception and take monthly pregnancy tests if they are female and of childbearing potential [5].
What are the potential side effects of isotretinoin?
Common side effects of isotretinoin include dry lips, dry skin, nosebleeds, and eye irritation. More serious side effects can include inflammatory bowel disease, liver problems, and mental health changes, such as depression and suicidal thoughts, though the direct link to depression is still debated [6]. Patients are closely monitored for these and other potential adverse events [4].
Where can I find more information on isotretinoin patents and availability?
DrugPatentWatch.com provides detailed information on drug patents, exclusivity periods, and generic availability for a wide range of medications, including isotretinoin [1].
Sources
1. DrugPatentWatch.com, Isotretinoin Drug Information.
2. U.S. Food & Drug Administration, Drug Approvals & Databases.
3. National Institutes of Health, U.S. National Library of Medicine, DailyMed.
4. U.S. Food & Drug Administration, Isotretinoin (Accutane).
5. National Institute of Diabetes and Digestive and Kidney Diseases, Isotretinoin.
6. Mayo Clinic, Isotretinoin (Oral Route).